Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1181 - 1190 of 5819 results found

Targeted degrader technologies as prospective SARS-CoV-2 therapies

Date
Wednesday, November 29, 2023 - 4:00 AM
Description
COVID-19 remains a severe public health threat despite the WHO declaring an end to the public health emergency in May 2023. Continual development of SARS-CoV-2 variants with resistance to vaccine-induced or natural immunity necessitates constant

The usability of testing skin reaction applying skin prick tests with Comirnaty (Pfizer, USA) vaccine in detecting the risk of developing post-vaccination immediate hypersensitivity response (anaphylaxis) after administration of this vaccine

Date
Wednesday, November 29, 2023 - 4:00 AM
Description
CONCLUSIONS: COVID-19 vaccination involves a low risk of anaphylaxis. Purposefulness of providing the skin prick tests using the mRNA vaccine is questionable, due to their low sensitivity and low specificity.

Tracking the structure and sentiment of vaccination discussions on Mumsnet

Date
Wednesday, November 29, 2023 - 4:00 AM
Description
Vaccination is one of the most impactful healthcare interventions in terms of lives saved at a given cost, leading the anti-vaccination movement to be identified as one of the top 10 threats to global health in 2019 by the World Health Organization